Table 1

Associations (χ2-tests/Fischers exact test) between the protein expression of ADAM9 in renal cell cancer and clinico-pathological parameters (percentages in brackets)


Total
low ADAM9
high ADAM9
p-value

All cases
108 (100)
71 (65.7)
37 (34.3)

Age



0.225
≤ 62
59 (54.6)
42 (71.2)
17 (28.8)

> 62
49 (45.4)
29 (59.2)
20 (40.8)

Histology



< 0.001
Clear cell
86 (79.6)
65 (75.6)
21 (24.4)

chromophobe
5 (4.6)
2 (40.0)
3 (60.0)

Papillary
17 (15.7)
4 (23.4)
13 (76.5)

pT-status



0.104
pT1
54 (50.0)
40 (74.1)
14 (25.9)

pT2/3/4
54 (50.0)
31 (57.4)
23 (42.6)

pN-status*



0.022
pN0
51 (47.2)
36 (70.6)
15 (29.4)

pN1
12 (11.1)
4 (33.3)
8 (66.7)

Grading



0.002
G 1
11 (10.2)
11(100)
0 (0)

G 2
75 (69.4)
50 (66.7)
25 (33.3)

G 3/4
22 (20.4)
10 (45.5)
12 (54.5)

Residual tumour status#



0.073
R0
78 (72.2)
56 (71.8)
22 (28.2)

R1/2
15 (13.9)
7 (46.7)
8 (53.3)

Metastasis



0.014
M0
85 (78.7)
61 (71.8)
24 (28.2)

M1
23 (21.3)
10 (43.5)
13 (56.5)


* 45 cases were pNx

# 15 cases were Rx

Fritzsche et al. BMC Cancer 2008 8:179   doi:10.1186/1471-2407-8-179